Taste of Italy 2 has acquired a 55% stake in Avantea, a leader in equine assisted reproduction services, to accelerate its growth and enhance its international presence.
Target Information
Taste of Italy 2, a private equity fund specializing in the agri-food sector and managed by DeA Capital Alternative Funds SGR, has acquired a 55% stake in Avantea S.r.l. The aim of this acquisition is to accelerate Avantea's growth and expand its international presence.
Founded in 2008 in Cremona by esteemed scientists Giovanna Lazzari and Cesare Galli, Avantea is a global leader in assisted reproduction services for competition horses. The company has revolutionized the industry by introducing Intracytoplasmic Sperm Injection (ICSI) technology, providing significant advantages for animal welfare and breeders. This minimally invasive technique is particularly beneficial for valuable stallions and competition mares, as it does not interfere with their competitive schedules.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
Avantea operates the world's largest ICSI laboratory and boasts proprietary formulations and methodologies developed over three decades of research and development, ensuring higher success rates than its competitors. The company collaborates with leading veterinary clinics across Europe, which ut
Similar Deals
Silver Economy Fund → Medical International Research (Mir)
2025
Silver Economy Fund → Mir-Medical International Research
2025
Quadrivio Group → Mir (Medical International Research)
2025
Silver Economy Fund → MIR – Medical International Research
2025
Silver Economy Fund (Quadrivio) → Biotec Italia
2025
Taste of Italy 2
invested in
Avantea S.r.l.
in 2024
in a Buyout deal
Disclosed details
Revenue: $10M